In: Panaitescu , C , Moffat , M A , Williams , S , Pinnock , H , Boros , M , Oana , C S , Alexiu , S & Tsiligianni , I 2014 , ' Barriers to the provision of smoking cessation assistance : a qualitative study among Romanian family physicians ' , Primary Care Respiratory Medicine , vol. 24 , 14022 . https://doi.org/10.1038/npjpcrm.2014.22 ; ISSN:2055-1010
BACKGROUND: Smoking cessation is the most effective intervention to prevent and slow down the progression of several respiratory and other diseases and improve patient outcomes. Romania has legislation and a national tobacco control programme in line with the World Health Organization Framework for Tobacco Control. However, few smokers are advised to quit by their family physicians (FPs). AIM: To identify and explore the perceived barriers that prevent Romanian FPs from engaging in smoking cessation with patients. METHODS: A qualitative study was undertaken. A total of 41 FPs were recruited purposively from Bucharest and rural areas within 600 km of the city. Ten FPs took part in a focus group and 31 participated in semistructured interviews. Analysis was descriptive, inductive and themed, according to the barriers experienced. RESULTS: Five main barriers were identified: limited perceived role for FPs; lack of time during consultations; past experience and presence of disincentives; patients' inability to afford medication; and lack of training in smoking cessation skills. Overarching these specific barriers were key themes of a medical and societal hierarchy, which undermined the FP role, stretched resources and constrained care. CONCLUSIONS: Many of the barriers described by the Romanian FPs reflected universally recognised challenges to the provision of smoking cessation advice. The context of a relatively hierarchical health-care system and limitations of time and resources exacerbated many of the problems and created new barriers that will need to be addressed if Romania is to achieve the aims of its National Programme Against Tobacco Consumption.
Maintaining healthcare for noncommunicable diseases (NCDs) is particularly important during the COVID-19 pandemic; however, diversion of resources to acute care, and physical distancing restrictions markedly affected management of NCDs. We aimed to assess the medication management practices in place for NCDs during the second wave of the COVID-19 pandemic across European countries. In December 2020, the European Network to Advance Best practices & technoLogy on medication adherencE (ENABLE) conducted a cross-sectional, web-based survey in 38 European and one non-European countries. Besides descriptive statistics of responses, nonparametric tests and generalized linear models were used to evaluate the impact on available NCD services of the number of COVID-19 cases and deaths per 100,000 inhabitants, and gross domestic product (GDP) per capita. Fifty-three collaborators from 39 countries completed the survey. In 35 (90%) countries face-to-face primary-care, and out-patient consultations were reduced during the COVID-19 pandemic. The mean ± SD number of available forms of teleconsultation services in the public healthcare system was 3 ± 1.3. Electronic prescriptions were available in 36 (92%) countries. Online ordering and home delivery of prescription medication (avoiding pharmacy visits) were available in 18 (46%) and 26 (67%) countries, respectively. In 20 (51%) countries our respondents were unaware of any national guidelines regarding maintaining medication availability for NCDs, nor advice for patients on how to ensure access to medication and adherence during the pandemic. Our results point to an urgent need for a paradigm shift in NCD-related healthcare services to assure the maintenance of chronic pharmacological treatments during COVID-19 outbreaks, as well as possible future disasters.
In: van Boven , J F , Tsiligianni , I , Potočnjak , I , Mihajlović , J , Dima , A L , Nabergoj Makovec , U , Ágh , T , Kardas , P , Ghiciuc , C M , Petrova , G , Bitterman , N , Kamberi , F , Culig , J , Wettermark , B & European Network to Advance Best Practices and Technology on Medication AdherencE (ENABLE) 2021 , ' European Network to Advance Best Practices and Technology on Medication Adherence : Mission Statement ' , Frontiers in Pharmacology , vol. 12 , 748702 . https://doi.org/10.3389/fphar.2021.748702 ; ISSN:1663-9812
Medication non-adherence is associated with almost 200,000 deaths annually and €80-125 billion in the European Union. Novel technological advances (smart pill bottles, digital inhalers and spacers, electronic pill blisters, e-injection pens, e-Health applications, big data) could help managing non-adherence. Healthcare professionals seem however inadequately informed about non-adherence, availability of technological solutions in daily practice is limited, and collaborative efforts to push forward their implementation are scarce. The European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action 19132) aims to 1) raise awareness of adherence enhancing solutions, 2) foster knowledge on medication adherence, 3) accelerate clinical application of novel technologies and 4) work collaboratively towards economically viable policy, and implementation of adherence enhancing technology across healthcare systems.
Medication non-adherence is associated with almost 200,000 deaths annually and €80–125 billion in the European Union. Novel technological advances (smart pill bottles, digital inhalers and spacers, electronic pill blisters, e-injection pens, e-Health applications, big data) could help managing non-adherence. Healthcare professionals seem however inadequately informed about non-adherence, availability of technological solutions in daily practice is limited, and collaborative efforts to push forward their implementation are scarce. The European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action 19132) aims to 1) raise awareness of adherence enhancing solutions, 2) foster knowledge on medication adherence, 3) accelerate clinical application of novel technologies and 4) work collaboratively towards economically viable policy, and implementation of adherence enhancing technology across healthcare systems.
Medication non-adherence is associated with almost 200,000 deaths annually and €80–125 billion in the European Union. Novel technological advances (smart pill bottles, digital inhalers and spacers, electronic pill blisters, e-injection pens, e-Health applications, big data) could help managing non-adherence. Healthcare professionals seem however inadequately informed about non-adherence, availability of technological solutions in daily practice is limited, and collaborative efforts to push forward their implementation are scarce. The European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action 19132) aims to 1) raise awareness of adherence enhancing solutions, 2) foster knowledge on medication adherence, 3) accelerate clinical application of novel technologies and 4) work collaboratively towards economically viable policy, and implementation of adherence enhancing technology across healthcare systems.
Medication non-adherence is associated with almost 200,000 deaths annually and €80–125 billion in the European Union. Novel technological advances (smart pill bottles, digital inhalers and spacers, electronic pill blisters, e-injection pens, e-Health applications, big data) could help managing non-adherence. Healthcare professionals seem however inadequately informed about non-adherence, availability of technological solutions in daily practice is limited, and collaborative efforts to push forward their implementation are scarce. The European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action 19132) aims to 1) raise awareness of adherence enhancing solutions, 2) foster knowledge on medication adherence, 3) accelerate clinical application of novel technologies and 4) work collaboratively towards economically viable policy, and implementation of adherence enhancing technology across healthcare systems.
Medication non-adherence is associated with almost 200,000 deaths annually and €80–125 billion in the European Union. Novel technological advances (smart pill bottles, digital inhalers and spacers, electronic pill blisters, e-injection pens, e-Health applications, big data) could help managing non-adherence. Healthcare professionals seem however inadequately informed about non-adherence, availability of technological solutions in daily practice is limited, and collaborative efforts to push forward their implementation are scarce. The European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action 19132) aims to 1) raise awareness of adherence enhancing solutions, 2) foster knowledge on medication adherence, 3) accelerate clinical application of novel technologies and 4) work collaboratively towards economically viable policy, and implementation of adherence enhancing technology across healthcare systems.
Background: In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. Main body: As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care. Conclusion: In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement. ; Partly funded by POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), and ...
International audience ; Background : In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy.Main body : As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care.Conclusion : In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
In: Bousquet , J J , Schünemann , H J , Togias , A , Erhola , M , Hellings , P W , Zuberbier , T , Agache , I , Ansotegui , I J , Anto , J M , Bachert , C , Becker , S , Bedolla-Barajas , M , Bewick , M , Bosnic-Anticevich , S , Bosse , I , Boulet , L P , Bourrez , J M , Brusselle , G , Chavannes , N , Costa , E , Cruz , A A , Czarlewski , W , Fokkens , W J , Fonseca , J A , Gaga , M , Haahtela , T , Illario , M , Klimek , L , Kuna , P , Kvedariene , V , Le , L T T , Larenas-Linnemann , D , Laune , D , Lourenço , O M , Menditto , E , Mullol , J , Okamoto , Y , Papadopoulos , N , Pham-Thi , N , Picard , R , Pinnock , H , Roche , N , Roller-Wirnsberger , R E , Rolland , C , Samolinski , B , Sheikh , A , Toppila-Salmi , S , Tsiligianni , I , Valiulis , A , Valovirta , E , Vasankari , T , Ventura , M T , Walker , S , Williams , S , Akdis , C A , Annesi-Maesano , I , Arnavielhe , S , Basagana , X , Bateman , E , Bedbrook , A , Bennoor , K S , Benveniste , S , Bergmann , K C , Bialek , S , Billo , N , Bindslev-Jensen , C , Bjermer , L , Blain , H , Bonini , M , Bonniaud , P , Bouchard , J , Briedis , V , Brightling , C E , Brozek , J , Buhl , R , Buonaiuto , R , Canonica , G W , Cardona , V , Carriazo , A M , Carr , W , Cartier , C , Casale , T , Cecchi , L , Cepeda Sarabia , A M , Chkhartishvili , E , Chu , D K , Cingi , C , Colgan , E , De Sousa , J C , Courbis , A L , Custovic , A , Cvetkosvki , B , Damato , G , Da Silva , J , Dantas , C , Dokic , D , Dauvilliers , Y , Dedeu , A , De Feo , G , Devillier , P , Di Capua , S , Dykewickz , M , Dubakiene , R , Ebisawa , M , El-Gamal , Y , Eller , E , Emuzyte , R , Farrell , J , Fink-Wagner , A , Fiocchi , A , Fontaine , J F , Gemicioǧlu , B , Schmid-Grendelmeir , P , Gamkrelidze , A , Garcia-Aymerich , J , Gomez , M , Diaz , S G , Gotua , M , Guldemond , N A , Guzmán , M A , Hajjam , J , O'Hourihane , J B , Humbert , M , Iaccarino , G , Ierodiakonou , D , Ivancevich , J C , Joos , G , Jung , K S , Jutel , M , Kaidashev , I , Kalayci , O , Kardas , P , Keil , T , Khaitov , M , Khaltaev , N , Kleine-Tebbe , J , Kowalski , M L , Kritikos , V , Kull , I , Leonardini , L , Lieberman , P , Lipworth , B , Lodrup Carlsen , K C , Loureiro , C C , Louis , R , Mair , A , Marien , G , Mahboub , B , Malva , J , Manning , P , De Manuel Keenoy , E , Marshall , G D , Masjedi , M R , Maspero , J F , Mathieu-Dupas , E , Matricardi , P M , Melén , E , Melo-Gomes , E , Meltzer , E O , Mercier , J , Miculinic , N , Mihaltan , F , Milenkovic , B , Moda , G , Mogica-Martinez , M D , Mohammad , Y , Montefort , S , Monti , R , Morais-Almeida , M , Mösges , R , Münter , L , Muraro , A , Murray , R , Naclerio , R , Napoli , L , Namazova-Baranova , L , Neffen , H , Nekam , K , Neou , A , Novellino , E , Nyembue , D , O'Hehir , R , Ohta , K , Okubo , K , Onorato , G , Ouedraogo , S , Pali-Schöll , I , Palkonen , S , Panzner , P , Park , H S , Pépin , J L , Pereira , A M , Pfaar , O , Paulino , E , Phillips , J , Plavec , D , Popov , T A , Portejoie , F , Price , D , Prokopakis , E P , Pugin , B , Raciborski , F , Rajabian-Söderlund , R , Reitsma , S , Rodo , X , Romano , A , Rosario , N , Rottem , M , Ryan , D , Salimäki , J , Sanchez-Borges , M M , Sisul , J C , Solé , D , Somekh , D , Sooronbaev , T , Sova , M , Spranger , O , Stellato , C , Stelmach , R , Ulrik , C S , Thibaudon , M , To , T , Todo-Bom , A , Tomazic , P V , Valero , A A , Valenta , R , Valentin-Rostan , M , Van Der Kleij , R , Vandenplas , O , Vezzani , G , Viart , F , Viegi , G , Wallace , D , Wagenmann , M , Wang , D Y , Waserman , S , Wickman , M , Williams , D M , Wong , G , Wroczynski , P , Yiallouros , P K , Yorgancioglu , A , Yusuf , O M , Zar , H J , Zeng , S , Zernotti , M , Zhang , L , Zhong , N S & Zidarn , M 2019 , ' Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases ' , Clinical and Translational Allergy , vol. 9 , 44 . https://doi.org/10.1186/s13601-019-0279-2
Background: In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. Main body: As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhi-nitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care. Conclusion: In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
BackgroundIn all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy.Main bodyAs an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care.ConclusionIn 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
In: Bousquet , J J , Schünemann , H J , Togias , A , Erhola , M , Hellings , P W , Zuberbier , T , Agache , I , Ansotegui , I J , Anto , J M , Bachert , C , Becker , S , Bedolla-Barajas , M , Bewick , M , Bosnic-Anticevich , S , Bosse , I , Boulet , L P , Bourrez , J M , Brusselle , G , Chavannes , N , Costa , E , Cruz , A A , Czarlewski , W , Fokkens , W J , Fonseca , J A , Gaga , M , Haahtela , T , Illario , M , Klimek , L , Kuna , P , Kvedariene , V , Le , L T T , Larenas-Linnemann , D , Laune , D , Lourenço , O M , Menditto , E , Mullol , J , Okamoto , Y , Papadopoulos , N , Pham-Thi , N , Picard , R , Pinnock , H , Roche , N , Roller-Wirnsberger , R E , Rolland , C , Samolinski , B , Sheikh , A , Toppila-Salmi , S , Tsiligianni , I , Valiulis , A , Valovirta , E , Vasankari , T , Ventura , M T , Walker , S , Williams , S , Akdis , C A , Annesi-Maesano , I , Arnavielhe , S , Basagana , X , Bateman , E , Bedbrook , A , Bennoor , K S , Benveniste , S , Bergmann , K C , Bialek , S , Billo , N , Bindslev-Jensen , C , Bjermer , L , Blain , H , Bonini , M , Bonniaud , P , Bouchard , J , Briedis , V , Brightling , C E , Brozek , J , Buhl , R , Buonaiuto , R , Canonica , G W , Cardona , V , Carriazo , A M , Carr , W , Cartier , C , Casale , T , Cecchi , L , Cepeda Sarabia , A M , Chkhartishvili , E , Chu , D K , Cingi , C , Colgan , E , De Sousa , J C , Courbis , A L , Custovic , A , Cvetkosvki , B , Damato , G , Da Silva , J , Dantas , C , Dokic , D , Dauvilliers , Y , Dedeu , A , De Feo , G , Devillier , P , Di Capua , S , Dykewickz , M , Dubakiene , R , Ebisawa , M , El-Gamal , Y , Eller , E , Emuzyte , R , Farrell , J , Fink-Wagner , A , Fiocchi , A , Fontaine , J F , Gemicioǧlu , B , Schmid-Grendelmeir , P , Gamkrelidze , A , Garcia-Aymerich , J , Gomez , M , Diaz , S G , Gotua , M , Guldemond , N A , Guzmán , M A , Hajjam , J , O'Hourihane , J B , Humbert , M , Iaccarino , G , Ierodiakonou , D , Ivancevich , J C , Joos , G , Jung , K S , Jutel , M , Kaidashev , I , Kalayci , O , Kardas , P , Keil , T , Khaitov , M , Khaltaev , N , Kleine-Tebbe , J , Kowalski , M L , Kritikos , V , Kull , I , Leonardini , L , Lieberman , P , Lipworth , B , Lodrup Carlsen , K C , Loureiro , C C , Louis , R , Mair , A , Marien , G , Mahboub , B , Malva , J , Manning , P , De Manuel Keenoy , E , Marshall , G D , Masjedi , M R , Maspero , J F , Mathieu-Dupas , E , Matricardi , P M , Melén , E , Melo-Gomes , E , Meltzer , E O , Mercier , J , Miculinic , N , Mihaltan , F , Milenkovic , B , Moda , G , Mogica-Martinez , M D , Mohammad , Y , Montefort , S , Monti , R , Morais-Almeida , M , Mösges , R , Münter , L , Muraro , A , Murray , R , Naclerio , R , Napoli , L , Namazova-Baranova , L , Neffen , H , Nekam , K , Neou , A , Novellino , E , Nyembue , D , O'Hehir , R , Ohta , K , Okubo , K , Onorato , G , Ouedraogo , S , Pali-Schöll , I , Palkonen , S , Panzner , P , Park , H S , Pépin , J L , Pereira , A M , Pfaar , O , Paulino , E , Phillips , J , Plavec , D , Popov , T A , Portejoie , F , Price , D , Prokopakis , E P , Pugin , B , Raciborski , F , Rajabian-Söderlund , R , Reitsma , S , Rodo , X , Romano , A , Rosario , N , Rottem , M , Ryan , D , Salimäki , J , Sanchez-Borges , M M , Sisul , J C , Solé , D , Somekh , D , Sooronbaev , T , Sova , M , Spranger , O , Stellato , C , Stelmach , R , Ulrik , C S , Thibaudon , M , To , T , Todo-Bom , A , Tomazic , P V , Valero , A A , Valenta , R , Valentin-Rostan , M , Van Der Kleij , R , Vandenplas , O , Vezzani , G , Viart , F , Viegi , G , Wallace , D , Wagenmann , M , Wang , D Y , Waserman , S , Wickman , M , Williams , D M , Wong , G , Wroczynski , P , Yiallouros , P K , Yorgancioglu , A , Yusuf , O M , Zar , H J , Zeng , S , Zernotti , M , Zhang , L , Zhong , N S , Zidarn , M , the ARIA Study Group & the MASK Study Group 2019 , ' Next-generation ARIA care pathways for rhinitis and asthma : A model for multimorbid chronic diseases ' , Clinical and Translational Allergy , vol. 9 , no. 1 , 44 . https://doi.org/10.1186/s13601-019-0279-2
Background: In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. Main body: As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhi-nitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care. Conclusion: In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
In: Bousquet , J J , Schünemann , H J , Togias , A , Erhola , M , Hellings , P W , Zuberbier , T , Agache , I , Ansotegui , I J , Anto , J M , Bachert , C , Becker , S , Bedolla-Barajas , M , Bewick , M , Bosnic-Anticevich , S , Bosse , I , Boulet , L P , Bourrez , J M , Brusselle , G , Chavannes , N , Costa , E , Cruz , A A , Czarlewski , W , Fokkens , W J , Fonseca , J A , Gaga , M , Haahtela , T , Illario , M , Klimek , L , Kuna , P , Kvedariene , V , Le , L T T , Larenas-Linnemann , D , Laune , D , Lourenço , O M , Menditto , E , Mullol , J , Okamoto , Y , Papadopoulos , N , Pham-Thi , N , Picard , R , Pinnock , H , Roche , N , Roller-Wirnsberger , R E , Rolland , C , Samolinski , B , Sheikh , A , Toppila-Salmi , S , Tsiligianni , I , Bindslev-Jensen , C , Eller , E , Ulrik , C S & ARIA Study Group 2019 , ' Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases ' , Clinical and Translational Allergy , vol. 9 , 44 . https://doi.org/10.1186/s13601-019-0279-2
Background: In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. Main body: As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care. Conclusion: In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
International audience ; Background : In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy.Main body : As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care.Conclusion : In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system for integrated care with organizational health literacy. MASK (Mobile Airways Sentinel NetworK) (1), a new development of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health) (2), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing reallife integrated care pathways (ICPs) (3)-centred around the patient with rhinitis and using mHealth monitoring of environmental exposure (4). An expert meeting took place at the Pasteur Institute in Paris, December 3, 2018. The aim was to discuss nextgeneration care pathways: (I) Patient participation, health literacy and self-care through technology-assisted "patient activation"; (II) Implementation of care pathways by pharmacists and (III) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) assessed by mobile technology. The EU (5) and global political agendas are of great importance in supporting health care transformation. MASK has been recognized by DG Santé as a Good Practice (6) in the field of digitally-enabled, integrated, person-centred care. The one-day meeting objectives were clear (Figure 1). The meeting was followed by a workshop. The present paper reports the background of the two-day meeting. [.] ; info:eu-repo/semantics/publishedVersion